106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
Order additional copies at GuidelineCentral.com
Copyright © 2020 All rights reserved
ASCOHBV10203b
Disclaimer
is pocket guide is derived om recommendations in the American Society of Clinical Oncology
Guideline. is resource is a practice tool based on ASCO® practice guidelines and is not intended to
substitute for the independent professional judgment of the treating physician. Practice guidelines
do not account for individual variation among patients. is pocket guide does not purport to
suggest any particular course of medical treatment. Use of the practice guidelines and this resource
are voluntary. e practice guidelines and additional information are available at www.asco.org/
supportive-care-guidelines. Copyright © 2020 by American Society of Clinical Oncology.
All rights reserved.
Abbreviations
ALT, alanine aminotransferase; anti-HBc, hepatitis B core antibody; anti-HBs, antibody to
hepatitis B surface antigen; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; mos,
months; PCR, polymerase chain reaction
Source
Hwang JP, Feld JJ, Hammond SP, et al. Hepatitis B Virus Screening and Management
for Patients With Cancer Prior to erapy: ASCO Provisional Clinical Opinion Update
[published online ahead of print, 2020 Jul 27]. J Clin Oncol. 2020; JCO2001757.
doi:10.1200/JCO.20.01757
Recommendation Grading
Type Benefit/harm
Strength of
Recommendation
EB Evidence- based B Benefits outweigh harms Strong
CB/FC
Consensus- based/
Formal Consensus
H Harms outweigh benefits Moderate
IC Informal consensus B/H
Relative balance of
benefits and harms
Weak
N
No
recommendation
U
Benefits/harms ratio
uncertain
ASCO believes that cancer clinical trials are vital to inform medical decisions and
improve cancer care and that all patients should have the opportunity to participate.
Additional information, which may include data supplements, slide sets, and other clinical
tools and resources, is available at www.asco.org/supportive-care-guidelines.